FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1231750004: Product containing precisely chlorzoxazone 250 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Defined. Date: 30-Jun 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5074113017 Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet en Synonym Active Case insensitive SNOMED CT core
5074114011 Acetaminophen 325 mg and chlorzoxazone 250 mg and diclofenac sodium 50 mg oral tablet en Synonym Active Case insensitive SNOMED CT core
5074115012 Product containing precisely chlorzoxazone 250 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet Is a Chlorzoxazone and diclofenac and paracetamol only product in oral dose form true Inferred relationship Some
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet Has manufactured dose form Conventional release oral tablet true Inferred relationship Some
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet Has unit of presentation Tablet true Inferred relationship Some
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet Has precise active ingredient Paracetamol true Inferred relationship Some 1
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet Has BoSS Paracetamol true Inferred relationship Some 1
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet Has precise active ingredient Chlorzoxazone true Inferred relationship Some 2
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet Has BoSS Chlorzoxazone true Inferred relationship Some 2
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 2
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 2
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet Has precise active ingredient Diclofenac sodium true Inferred relationship Some 3
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet Has BoSS Diclofenac sodium true Inferred relationship Some 3
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 3
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 3

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start